These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 5406542
1. [Experimental study of the use of magnesium and of ajmaline in ventricular bathmotropic disorders secondary to acute coronary occlusion]. Critelli G, Cernigliaro C, Rizzo S, Santucci A, Marigliano V, Giuliano G. Atti Soc Ital Cardiol; 1969 Jan 21; 2():270-81. PubMed ID: 5406542 [No Abstract] [Full Text] [Related]
3. Electropharmacology of the rauwolfia alkaloids, ajmaline tetraphyllicine, and serpentine on the canine heart. Duncan RJ, Nash CB. Arch Int Pharmacodyn Ther; 1973 Nov 21; 206(1):181-90. PubMed ID: 4775934 [No Abstract] [Full Text] [Related]
4. [Action of ajmaline on atrioventricular conduction and on experimental ventricular tachycardia]. Medrano GA, Cantú M, Cisneros F, De Micheli A. Arch Inst Cardiol Mex; 1968 Nov 21; 38(5):682-91. PubMed ID: 5702939 [No Abstract] [Full Text] [Related]
5. [Effects of ajmaline and of dimonchloracetylajmaline on atrioventricular and intraventricular conduction in man]. Knippel M, Cadel A, Mazzini C, Figini A, Rovelli F. G Ital Cardiol; 1971 Nov 21; 1(4):321-30. PubMed ID: 5126214 [No Abstract] [Full Text] [Related]
6. Control of arrhythmias following ligation of the circumflex artery. Armiger LC, Elswijk JG. J Thorac Cardiovasc Surg; 1975 Jun 21; 69(6):891-4. PubMed ID: 166259 [Abstract] [Full Text] [Related]
7. Early arrhythmias following experimental coronary occlusion in conscious dogs and their modification by beta-adrenoceptor blocking drugs. Khan MI, Hamilton JT, Manning GW. Am Heart J; 1973 Sep 21; 86(3):347-58. PubMed ID: 4146951 [No Abstract] [Full Text] [Related]
9. [Effects of the beta-blocking agent atenolol on arrhythmias especially ventricular fibrillation and fibrillation threshold after acute experimental coronary artery occlusion (author's transl)]. Abendroth RR, Meesmann W, Stephan K, Schley G, Hübner H. Z Kardiol; 1977 Jul 21; 66(7):341-50. PubMed ID: 899134 [No Abstract] [Full Text] [Related]
10. [1st experimental results on antiarrhythmic activity of an acetylated derivative of ajmaline: dichloro-acetyl-ajmaline]. Botti G, Visioli O, Barbaresi F, Lazzari GB. Boll Soc Ital Cardiol; 1966 Jul 21; 11(1):135-41. PubMed ID: 5938064 [No Abstract] [Full Text] [Related]
11. [Antiarrhythmic activity of ajmaline obtained from Rauwolfia serpentina biomass grown in tissue culture]. Kostin IaV, Tsybusov AP, Minina SA, Kuznetsova VA, Borodulina MV, Balashov VP. Kardiologiia; 1990 Aug 21; 30(8):72-4. PubMed ID: 2255150 [Abstract] [Full Text] [Related]
12. [Pharmacology of N-propyl-ajmaline bromide (NPAB)]. Gendenshteĭn EI. Farmakol Toksikol; 1970 Aug 21; 33(3):303-5. PubMed ID: 5453025 [No Abstract] [Full Text] [Related]
13. Cesium in the prevention of cardiac arrhythmias induced by coronary ligation. Prasad K, Simani AS, Dolan AM, Sterns LP, Callaghan JC. Surg Forum; 1970 Aug 21; 21():166-7. PubMed ID: 5514720 [No Abstract] [Full Text] [Related]
14. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat. Diederich KW, Boyksen D. Arzneimittelforschung; 1973 Sep 21; 23(9):1302-5. PubMed ID: 4801225 [No Abstract] [Full Text] [Related]
15. Experimental and clinical effects of bretylium tosylate on ventricular fibrillation, arrhythmias, and heart block. Bacaner M. Geriatrics; 1971 Jan 21; 26(1):132-48. PubMed ID: 5539447 [No Abstract] [Full Text] [Related]